Himalaya Liv 52 DS

Description

Himalaya Liv 52 DS was introduced in 1955 by Himalaya Herbal Healthcare. Since then, it has been sold worldwide and is recognized by thousands of health professionals as one of the most effective liver formulas, with beneficial effects reported in over 300 studies on a variety of cases. Himalaya Liv 52 DS is a unique, all-natural, complex multi-ingredient formula. It is safe and effective in protecting the liver against harmful toxins from drugs, alcohol, food and water. Himalaya Liv 52 DS helps regulate levels of enzymes and optimizes assimilation. Himalaya Liv 52 DS has also been found to be associated with an increase in serum albumin, which is another indication of the liver protection it provides. Recent work shows that Himalaya Liv 52 DS has cholesterol-regulating action. Clinically, it helps maintain healthy levels of serum cholesterol, lipoproteins, phospholipids and triglycerides.

Himalaya Liv 52 DS Ingredients:
Each Herbal Liv 52 DS tablet contains –
Himsra (Capparis spinosa) 130mg

Kasani (Cichorium intybus) 130mg

Mandur bhasma 66mg

Kakamachi (Solanum nigrum) 64mg

Arjuna (Terminalia arjuna) 64mg

Kasamarda (Cassia occidentalis) 32mg

Biranjasipha (Achillea millefolium) 32mg

Jhavuka (Tamarix gallica) 32mg

Herbal Liv 52 DS Tablets Usage:
Herbal Liv 52 DS Tablets are useful in the prevention and treatment of:

Viral hepatitis

Alcoholic liver disease

Pre-cirrhotic conditions and early cirrhosis

Protein energy malnutrition

Loss of appetite

Radiation and chemotherapy-induced liver damage

Herbal Liv 52 DS Dosage:
Please consult your physician to prescribe the dosage that best suits your condition.

Herbal Liv 52 DS Side Effects:
There is no site effects reported if taken as per the prescribed dosage.

Herbal Liv 52 DS Clinical Studies:
Evaluation of efficacy and safety of Liv 52 DS tablets in acute viral hepatitis: A prospective, double-blind, randomized, placebo-controlled, phase III clinical trial – Dr. Rajiv Baijal, M.D., D.N.B.1, Dr. Nikhil Patel, M.D.,2 and Dr. S. A. Kolhapure, M.D.3* 1Gastroenterologist, 2Research Associates, Department of Gastroenterology, Jagjivanram Western Railway Hospital, Mumbai Central, Mumbai, India, 3Senior Medical Advisor, R&D Center, The Himalaya Drug Company, Bangalore, India, Medicine Update 2004; 12(5), 41-53.

Studies with Liv 52 therapy in infective hepatitis – Sule, C.R., Pai, V.R., Damania, R.F. and Joshi, V.S. (Miss.), Medicine Unit, Sasoon General Hospitals and B.J. Medical College, Poona, Maharashtra, Journal of Indian Medical Profession (1968): 14, 6391.

Blood, urine ethanol and acetaldehyde levels from six different alcoholic beverages and effect of Liv 52 – Kulkarni, R.D. and Chauhan, B.L., R&D Centre, The Himalaya Drug Co., Bombay, Maharashtra, European Journal of Pharmacology (1990): (183), 5, 1865.